Source: Owler

Cardiovascular System, Inc.: CSI's revenue changed from $237.53M in Sep 2022 to $239.84M in Dec 2022

CSI’s Trailing Twelve Months revenue changed from $237.53M in Sep 2022 to $239.84M in Dec 2022 increasing 1.0% in this time period.

Cardiovascular System, Inc.'s Competitors | Cardiovascular System, Inc.'s News | Cardiovascular System, Inc.'s Financials

Followers on Owler

206

Est. Annual Revenue

$100-500M

Est. Employees

250-500

Chairman & CEO

Scott R. Ward

CEO Approval Rating

63/100

CSI is a Minnesota-based medical device company that develops and commercializes interventional products for the treatment of peripheral and coronary vascular diseases.